Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Wade Marteene, Karl Winckel, Sam Hollingworth, Steve Kisely, Erin Gallagher, Margaret Hahn, Bjørn H Ebdrup, Joseph Firth & Dan Siskind. (2019) Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety 18:12, pages 1149-1160.
Read now
Read now
Blazej Misiak, Dorota Frydecka, Patryk Piotrowski & Andrzej Kiejna. (2013) The Multidimensional Nature of Metabolic Syndrome in Schizophrenia: Lessons from Studies of One-Carbon Metabolism and DNA Methylation. Epigenomics 5:3, pages 317-329.
Read now
Read now
Brenda Happell, Chris Platania-Phung & David Scott. (2013) Survey of Australian mental health nurses on physical activity promotion. International Journal of Mental Health Promotion 15:3, pages 148-161.
Read now
Read now
Frank I Tarazi & Stephen M Stahl. (2012) Iloperidone, asenapine and lurasidone: a primer on their current status. Expert Opinion on Pharmacotherapy 13:13, pages 1911-1922.
Read now
Read now
Susanne H. Stanley & Jonathan D. E. Laugharne. (2011) Clinical guidelines for the physical care of mental health consumers: a comprehensive assessment and monitoring package for mental health and primary care clinicians. Australian and New Zealand Journal of Psychiatry 45:10, pages 824-829.
Read now
Read now
Meng-Chang Tsai, Chia-Ming Chang, Chia-Yih Liu, Pi-Yueh Chang & Tiao-Lai Huang. (2011) Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls. International Journal of Psychiatry in Clinical Practice 15:2, pages 106-111.
Read now
Read now
Karen J. Dodd, Sean Duffy, Jan A. Stewart, Jennifer Impey & Nicholas Taylor. (2011) A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study. Disability and Rehabilitation 33:13-14, pages 1222-1229.
Read now
Read now
Armineh Zohrabian. (2010) Clinical and economic considerations of antiobesity treatment: a review of orlistat. ClinicoEconomics and Outcomes Research 2, pages 63-74.
Read now
Read now
Michelle N Sicard, Clement C Zai, Arun K Tiwari, Renan P Souza, Herbert Y Meltzer, Jeffrey A Lieberman, James L Kennedy & Daniel J Müller. (2010) Polymorphisms of the HTR2C Gene and Antipsychotic-Induced Weight Gain: An Update and Meta-Analysis. Pharmacogenomics 11:11, pages 1561-1571.
Read now
Read now
Sarah Hetrick, Mario Álvarez-Jiménez, Alexandra Parker, Frank Hughes, Michaela Willet, Katherine Morley, Richard Fraser, Patrick D. McGorry & Andrew Thompson. (2010) Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic. Australasian Psychiatry 18:5, pages 451-455.
Read now
Read now
Hector W. H. Tsang, Mandy W. M. Fong, Kelvin M. T. Fung & Raymond C. K. Chung. (2010) Perceptions on efficacy and side effects of conventional depot antipsychotics (CDA) and atypical depot antipsychotics (ADA): Psychiatrists versus patients in Hong Kong. International Journal of Psychiatry in Clinical Practice 14:1, pages 23-32.
Read now
Read now
Tamás Treuer, Vicki Poole Hoffmann, Antony Kuang-Peng Chen, Victoria Irimia, Magdalena Ocampo, Gang Wang, Pritibha Singh & Susanna Holt. (2009) Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study. The World Journal of Biological Psychiatry 10:4-3, pages 729-740.
Read now
Read now
Carol L. Galletly & Leslie E. Murray. (2009) Managing Weight in Persons Living with Severe Mental Illness in Community Settings: A Review of Strategies Used in Community Interventions. Issues in Mental Health Nursing 30:11, pages 660-668.
Read now
Read now